CYTEK BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.2M | — | $-6.5M | $-4.4M | $-6.8M | $1.6M | $-702.0K | $-2.2M |
| Depreciation & Amortization | $1.7M | — | — | — | $1.0M | — | — | $794.0K |
| Depreciation | $800.0K | — | $900.0K | $600.0K | $500.0K | $400.0K | $400.0K | $300.0K |
| Amortization | $900.0K | — | $900.0K | $1.0M | $500.0K | $200.0K | $500.0K | $453.0K |
| Stock-Based Compensation | $5.6M | — | — | — | $4.7M | — | — | $3.8M |
| Net Cash from Operating Activities | $4.0M | — | $-4.2M | $-2.9M | $2.9M | $-7.5M | $-9.4M | $-1.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $567.0K | — | $1.3M | $1.3M | $505.0K | $1.1M | $1.3M | $780.0K |
| Business Acquisitions | $0 | — | — | — | $44.9M | — | — | $0 |
| Net Cash from Investing Activities | $-5.8M | — | — | — | $-168.9M | — | — | $-780.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $34.6M | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.6M | — | — | — | $0 | — | — | $364.0K |
| Net Change in Cash | $1.5M | — | — | — | $-167.1M | — | — | $-2.1M |
| Free Cash Flow | $3.4M | — | $-5.6M | $-4.2M | $2.4M | $-8.6M | $-10.8M | $-2.3M |